Overview

Medical Chitosan or Sodium Hyaluronate for Knee Osteoarthritis (CHOOSE)

Status:
Unknown status
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
This study evaluates the safety and efficacy of investigational products in the treatment of knee Osteoarthritis. Half of participants will receive medical chitosan, while the other half will receive sodium hyaluronate.
Phase:
Phase 4
Details
Lead Sponsor:
Shanghai Qisheng Biological Preparation Co., Ltd.
Treatments:
Chitosan
Hyaluronic Acid